Injury Recovery

Injury Recovery

Peptides researched for tendon, ligament, bone, and nerve healing. Covers tissue regeneration and repair following acute or chronic injury. Each compound links to its full dosing protocol.

Research Use Only. All dosing information is for educational purposes. Consult a licensed healthcare provider before making health decisions.

BPC-157

The gold standard recovery peptide. Accelerates healing of tendons, ligaments, muscles, and bones through angiogenesis, anti-inflammation, and growth factor modulation.

Quick Dosing Reference (5 mg vial):
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → 1.67 mg/mL concentration
Dose Range: 200–600 mcg once daily (gradual titration)
Cycle: 8–12 weeks; optional extension to 16 weeks
Schedule: Weeks 1–2: 200 mcg → Weeks 3–4: 400 mcg → Weeks 5–8+: 600 mcg → Weeks 1–2: 200 mcg

TB-500

Promotes cell migration to injury sites and stimulates new blood vessel formation. Researched for tendon/ligament repair, reducing scar tissue, and improving tissue flexibility post-injury.

Quick Dosing Reference (5 mg vial):
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration
Dose Range: 500–1000 mcg once daily (gradual titration recommended)
Cycle: 8–12 weeks; optional extension to 16 weeks
Schedule: Weeks 1–2: 500 mcg 30 → Weeks 3–4: 600 mcg 36 → Weeks 5–8: 750 mcg 45 → Weeks 9–12: 1000 mcg 60

GHK-Cu

Copper peptide that attracts immune and stem cells to injury sites. Promotes wound contraction, collagen remodeling, and nerve regeneration for comprehensive tissue repair.

Quick Dosing Reference (50 mg vial):
Route: Subcutaneous injection
Reconstitution: 3.0 mL sterile water → 16.67 mg/mL concentration
Dose Range: 1–2 mg once daily (gradual titration over 12 weeks)
Cycle: 8–12 weeks typical; may extend to 16 weeks

IGF-1 LR3

Long-acting growth factor that promotes cell proliferation and tissue regeneration. Key mediator of growth hormone effects on muscle, bone, and connective tissue repair.

Quick Dosing Reference (1 mg vial):
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → ~0.333 mg/mL concentration
Dose Range: 20–50 mcg once daily subcutaneously (gradual titration recommended)
Cycle: 8 weeks standard; 12-week protocols exist but may show diminished returns beyond Week 6–8
Schedule: Weeks 1–2: 20 mcg → Weeks 3–4: 40 mcg → Weeks 5–8: 50 mcg
Research — Injury Recovery:

ARA-290

Non-erythropoietic EPO-derived peptide that acts on innate repair receptor. Researched for neuropathic pain relief, nerve regeneration, and promoting tissue repair without red blood cell effects.

Quick Dosing Reference (16 mg vial):
Route: Subcutaneous injection
Reconstitution: 2.0 mL Phosphate Buffered Saline (PBS) → 8 mg/mL concentration
Cycle: 4–8 weeks standard; may extend to 16 weeks based on individual assessment
Schedule: Week 1: 2 mg

SS-31 (Elamipretide)

Mitochondria-targeted peptide that restores cellular energy production post-injury. Protects against ischemia-reperfusion damage and supports tissue recovery at the mitochondrial level.

Quick Dosing Reference (10 mg vial):
Route: Subcutaneous injection
Reconstitution: 1.0 mL bacteriostatic water → 10 mg/mL concentration
Dose Range: 5–10 mg once daily (gradual titration); advanced protocols may reach 15–20 mg/day under supervision
Cycle: 8–12 weeks; limited data exists beyond 12 weeks
Schedule: Weeks 1–2: 5 mg → Weeks 3–8: 10 mg → Weeks 5–8: 15 mg Split: → Weeks 9–12: 20 mg Split:

All information is intended strictly for educational and research purposes. Not medical advice. Consult a licensed healthcare provider before making any health decisions.

Scroll to Top